These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1601393)

  • 41. Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue.
    Howden CW; Burget DW; Silletti C; Van Eeden A; Tomkins KB; Hunt RH
    Aliment Pharmacol Ther; 1987 Aug; 1(4):305-13. PubMed ID: 2979675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Twenty-four-hour intragastric measurements in twenty healthy subjects: effect of enisoprost, a novel and potent antisecretory and antipeptic synthetic E1 prostaglandin.
    Thomson AB; McCullough HN; Kirdeikis P; Zuk L; Simpson I; Cook DJ; Wildeman RA; Brunet K; Fisher D; Pinchbeck B
    Aliment Pharmacol Ther; 1988 Aug; 2(4):325-36. PubMed ID: 2979255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enisoprost in renal transplantation. The Enisoprost Renal Transplant Study Group.
    Adams MB
    Transplantation; 1992 Feb; 53(2):338-45. PubMed ID: 1738927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amiodarone-induced changes in lipid metabolism.
    Kasim SE; Bagchi N; Brown TR; Khilnani S; Jackson K; Steinman RT; Lehmann MH
    Horm Metab Res; 1990 Jul; 22(7):385-8. PubMed ID: 2401448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
    Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of high density lipoprotein cholesterol with plasma lipolytic activity and C-peptide concentration in type 2 diabetes.
    Baynes C; Rains SG; Wadsworth J; Wilson GA; Richmond W; Elkeles RS
    Diabetes Res; 1991 Feb; 16(2):49-53. PubMed ID: 1817805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment.
    Lam KS; Chan MK; Yeung RT
    Q J Med; 1986 May; 59(229):513-21. PubMed ID: 3763814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of the prostaglandin E1 analog enisoprost on glucose and lipid metabolism in patients with type II diabetes mellitus.
    Kasim SE; Moran M; Khilnani S; West MA; Jen KL
    Horm Metab Res; 1992 Apr; 24(4):176-80. PubMed ID: 1601393
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.